- Home
- VRAX vs WNW Comparison
VRAX vs WNW Comparison
Compare VRAX & WNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRAX
- WNW
- Stock Information
- Founded
- VRAX 2013
- WNW 2015
- Country
- VRAX United Kingdom
- WNW China
- Employees
- VRAX N/A
- WNW N/A
- Industry
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- WNW Catalog/Specialty Distribution
- Sector
- VRAX Health Care
- WNW Consumer Discretionary
- Exchange
- VRAX Nasdaq
- WNW Nasdaq
- Market Cap
- VRAX 4.7M
- WNW 5.3M
- IPO Year
- VRAX 2022
- WNW 2020
- Fundamental
- Price
- VRAX $0.79
- WNW $1.95
- Analyst Decision
- VRAX Strong Buy
- WNW
- Analyst Count
- VRAX 1
- WNW 0
- Target Price
- VRAX $3.00
- WNW N/A
- AVG Volume (30 Days)
- VRAX 38.7K
- WNW 61.8K
- Earning Date
- VRAX 02-05-2025
- WNW 07-07-2025
- Dividend Yield
- VRAX N/A
- WNW N/A
- EPS Growth
- VRAX N/A
- WNW N/A
- EPS
- VRAX N/A
- WNW 9.06
- Revenue
- VRAX $84,872.00
- WNW $158,485.00
- Revenue This Year
- VRAX $5,169.18
- WNW N/A
- Revenue Next Year
- VRAX $66.97
- WNW N/A
- P/E Ratio
- VRAX N/A
- WNW $0.19
- Revenue Growth
- VRAX 7.03
- WNW N/A
- 52 Week Low
- VRAX $0.74
- WNW $0.95
- 52 Week High
- VRAX $9.00
- WNW $70.00
- Technical
- Relative Strength Index (RSI)
- VRAX 31.75
- WNW 57.59
- Support Level
- VRAX $0.75
- WNW $1.74
- Resistance Level
- VRAX $0.85
- WNW $2.00
- Average True Range (ATR)
- VRAX 0.07
- WNW 0.17
- MACD
- VRAX -0.01
- WNW 0.03
- Stochastic Oscillator
- VRAX 6.57
- WNW 66.57
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.
About WNW Meiwu Technology Company Limited
Meiwu Technology Co Ltd operates as an online food retail store and franchise restaurants in China. The products offered include green food, organic food, intangible cultural heritage food products, agricultural products bearing geographical indications, and pollution-free products. It operates in three segments including Clean Food platform, Skincare products & service and Technical Service. The company generates the majority of its revenue from Technical services.